Unresectable Chemorefractory Liver Metastases: Radioembolization with90Y Microspheres—Safety, Efficacy, and Survival

Authors:
  • RLRobert J. Lewandowski
    Robert J. Lewandowski
  • MMMary F. Mulcahy
    Mary F. Mulcahy
  • BABassel Atassi
    Bassel Atassi
  • RRRobert K. Ryu
    Robert K. Ryu
  • ANAlbert A. Nemcek
    Albert A. Nemcek
  • OBOmar Barakat
    Omar Barakat
  • ABAl Benson
    Al Benson
  • RMRobert Mandal
    Robert Mandal
  • MTMark Talamonti
    Mark Talamonti
  • CWChing-Yee O. Wong
    Ching-Yee O. Wong

Abstract
Purpose: To prospectively evaluate the safety, efficacy, and survival of patients with chemorefractory liver metastases who have been treated with yttrium 90 (90Y) glass microspheres. Materials and Methods: Institutional review boards from two institutions approved the HIPAA-compliant study; all patients provided informed consent. One hundred thirty-seven patients underwent 225 administrations of 90Y microspheres by using intraarterial infusion. Primary sites (origins) included colon, breast, neuroendocrine, pancreas, lung, cholangiocarcinoma, melanoma, renal, esophageal, ovary, adenocarcinoma of unknown primary, lymphoma, gastric, duodenal, bladder, angiosarcoma, squamous cell carcinoma, thyroid, adrenal, and parotid. Patients underwent evaluation of baseline and follow-up liver function and tumor markers and computed tomographic or magnetic resonance imaging. Patients were observed for survival from first treatment. Median survival (in days) and corresponding 95% confidence intervals were computed by us...

This publication has 27 references indexed in Scilit: